Testing effectiveness (Phase 2)UnknownNCT04708340
What this trial is testing
Tolerability and Efficacy of RJX in Patients With COVID-19
Who this might be right for
COVID-19Acute Respiratory Distress SyndromeSARS-CoV-2+1 more
Reven Pharmaceuticals, Inc. 237